Fundraising Fox

Cidara Therapeutics

San Diego, US · Founded 2012 · Delaware corporation · 6 known investors

cidara.com ↗

Pharmaceutical company developing medicines and vaccines for patient health and treatment. Operating for over 130 years with focus on clinical research and drug development.

BiotechHealthtechin /merck@Merck

Founders & leadership

JS
Jeffrey SteinExecutive Officer, Director
SE
Steve ElmsDirector
DB
Dan BurgessDirector
TS
Ted SchroederDirector
KF
Kevin ForrestExecutive Officer
DT
Dirk ThyeExecutive Officer
KB
Ken BartizalExecutive Officer
KJ
Kevin JudiceDirector
PD
Paul DaruwalaExecutive Officer
SR
Scott RocklageDirector
NK
Nina KjellsonDirector
PH
Patrick HeronDirector

Investors · 6

Aisling CapitalNew York
Frazier Life SciencesPalo Altovia Patrick Heron · board
RA CapitalBoston
Vivo CapitalPalo Alto · $10M – $50M
5AM VenturesreportedBoston · $100K – $4Mvia Scott Rocklage · board
Canaan PartnersreportedStamford · $500K – $20Mvia Nina Kjellson · board

Reported raises · per SEC filings

Form D private placements
▶$240MraisedMay 2024 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Carin Canale-TheakstonDirector
  • Theodore R. SchroederDirector
  • Daniel D. BurgessDirector
  • Laura Tadvalkar, Ph.D.Director
  • Taylor Sandison, M.D.Executive Officer
  • Leslie Tari, Ph.D.Executive Officer
  • Preetam Shah, Ph.D.Executive Officer
  • Bonnie Bassler, Ph.D.Director
  • James Merson, Ph.D.Director
  • Ryan SpencerDirector
  • Shane WardExecutive Officer
  • Jeffrey Stein, Ph.D.Executive Officer, Director
Offering amount
$240M
Amount sold
$240M
First sale
Apr 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$9MraisedSep 2019 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeffrey SteinExecutive Officer, Director
  • Daniel D BurgessDirector
  • Theodore R SchroederDirector
  • David GollaherDirector
  • Timothy FransonDirector
  • Jessica OienExecutive Officer
  • Taylor SandisonExecutive Officer
  • Chrysa MineoDirector
  • James LevineExecutive Officer
  • Neil AbdollahianExecutive Officer
  • Paul DaruwalaExecutive Officer
Offering amount
$9M
Amount sold
$9M
First sale
Sep 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.6MraisedMay 2018 · 16 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Taylor SandisonExecutive Officer
  • Robert J PerezDirector
  • Theodore R SchroederDirector
  • Matthew OnaitisExecutive Officer
  • Jeffrey SteinExecutive Officer, Director
  • Timothy R FransonDirector
  • Daniel D BurgessDirector
  • Scott M RocklageDirector
  • Chrysa MineoDirector
Offering amount
$1.9M
Amount sold
$1.6M
Sales commissions
$1.9M
First sale
May 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$20.2MraisedOct 2017 · 16 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Daniel D BurgessDirector
  • Theodore R SchroederDirector
  • Timothy R FransonDirector
  • Kevin ForrestExecutive Officer
  • Ken BartizalExecutive Officer
  • Matthew OnaitisExecutive Officer
  • Jeffrey SteinExecutive Officer, Director
  • Taylor SandisonExecutive Officer
  • Neil AbdollahianExecutive Officer
  • Robert J PerezDirector
  • Paul DaruwalaExecutive Officer
  • Scott M RocklageDirector
Offering amount
$20.2M
Amount sold
$20.2M
Finders' fees
$1.1M
First sale
Oct 2017
Incorporated
Corporation, Delaware, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$42MraisedFeb 2015 · 19 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeffrey SteinExecutive Officer, Director
  • Steve ElmsDirector
  • Dan BurgessDirector
  • Scott RocklageDirector
  • Ted SchroederDirector
  • Kevin ForrestExecutive Officer
  • Dirk ThyeExecutive Officer
  • Ken BartizalExecutive Officer
  • Kevin JudiceDirector
  • Paul DaruwalaExecutive Officer
  • Nina KjellsonDirector
  • Patrick HeronDirector
Offering amount
$42M
Amount sold
$42M
First sale
Feb 2015
Incorporated
Corporation, Delaware, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.